Global Rare Neurological Disease Treatment Market Dominated by North America as Germany Emerges with Bayer AG & Pfizer
Germany strengthens its role as a biotech hub, driven by gene therapy, RNA treatments, and precision medicine, shaping neurological care through 2035. ROCKVILLE, MD, UNITED STATES, April 16, 2026 /EINPresswire.com/ -- According to the latest analysis by …